Suppression of immunity by some pesticides, xenobiotics, and industrial chemicals. In vitro model

Ilia Brondz, Anton Brondz

.
Department of Biology, University of Oslo, Blindern 0316, Oslo, Norway.

DOI: 10.4236/jbpc.2011.23028                

Abstract

In recent years, attention has focused on suppression of immunity in immunocompromised patients. The definition of immunocompromise is impairment of the immune system caused by a disease or treatment. In addition to disease and treatment, other factors such as exposure to pesticides or toxic chemicals can damage the immune system. An in vitro test was used to assess the ability of monochloroacetic acid (MCA) (CAS number 79-11-8), dichloroacetic acid (DCA) (CAS number 79-43-6), trichloroacetic acid (TCA) (CAS number 76-03-9), and 2,2- dichloropropionic acid sodium salt (2,2-DCPANa, Dalapon) (CAS number 127-20-8) to suppress bacteriolysis by hen egg white lysozyme (HEWL). The system for bacteriolysis of Gram-negative bacteria Actinobacillus, Haemophilus, and Pasteurella in Tris-maleate buffer supplemented with EDTA and HEWL developed by Brondz et al. [1–4] was used to monitor bacteriolysis of Gram-negative bacteria in the Actinobacillus–Haemophilus–Pasteurella group. The halogenated acetic acid DCA is produced as a toxic artifact of the degradation of TCA and by disinfection of drinking and pool water and industrial waste. Nearly all humans consume DCA in drinking water during their lifetime; the concentration of DCA in drinking water can be higher than that associated with the upper-bound excess life-time cancer risk of 10^–4 (40μg/L) [5]. Lysozyme found in tears, saliva, nasal secretions, and excretions from all mucous membranes can break down the cell walls of bacteria and destabilize bacterial membranes. Lysozyme is involved in innate (nonspecific) immunity; the innate immune system is the first line of defense against invading organisms. Actinobacillus actinomy- cetemcomitans (ATCC29522), a Gram-negative bacterium whose primary ecological niche is the respiratory tract and oral cavity, provided the peptidoglycan substrate for HEWL. The optical density (OD) of a standardized suspension of A. actinomycetemcomitans decreased from 100% (OD 0.6 at 540 nm) to 23.5% after exposure to EDTA/HEWL for 50 min. After 50 min of exposure to 10.0 mg/mL of MCA, DCA, TCA, or 2,2-DCPANa as a supplement, EDTA/HEWL-induced lysis of A. actinomycetemcomitans decreased to 66.3%, 66.8%, 65.7%, and 73.6%, respectively. The aim of the presented study was the development of a model for measuring possible immunotoxic effects of chemicals, degradation products, xenobiotics and metabolites by these chemicals on the immune system. The method used is an in vitro bacteriolysis of Gram- negative bacterium induced by HEWL, described previously [1-4]. In the present study, several halogenated acids, MCA, DCA, and TCA, and the Na salt of 2,2-DCPA, exhibited immunosuppressive activity. The ability of MCA, DCA, TCA, and 2,2-DCPANa (Dalapon) to suppress HEWL induced bacteriolysis was demonstrated in vitro. document.

Keywords

Immunosuppression; Immunotoxicity; Chlorinated Aliphatic Acids; Dalapon

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Brondz, I. (1985) Chemotaxonomy of selected species of the Actinobacillus-Haemophilus-Pasteurella group by means of gas chromatography, gas chromatography-mass spectrometry and bioenzymatic methods. PhD dissertation, University of Oslo, Oslo.
[2]	Brondz, I. and Olsen, I. (1986) (Review) Chemotaxonomy of selected species of the Actinobacillus-Haemo- philus-Pasteurella group by means of gas chromatography, gas chromatography-mass spectrometry and bioenzymatic methods. Journal of Chromatography, 380, 1-17.
[3]	Olsen, I. and Brondz, I. (1985) Differentiation among closely related organisms of the Actinobacillus-Haemo- philus-Pasteurella group by means of lysozyme and EDTA. Journal of Clinical Microbiology, 22, 629-636.
[4]	Brondz, I., Olsen, I. and Sj?str?m, M. (1990) Multivariate analysis of quantitative chemical and enzymatic characterization data in classification of Actinobacillus, Haemophilus and Pasteurella spp. The Journal of General Microbiology, 136, 507-513.
[5]	WHO/SDE/WSH/05.08/121 (2005) Dichloroacetic acid in drinking-water, background document for development of WHO guidelines for drinking-water quality. http://www.who.int/water_sanitation_health/dwq/chemicals/dichloroaceticacid0505.pdf
[6]	Johnson, L.N., (1998), The early history of lysozyme. Nature Structural & Molecular Biology, 5, 942-944. doi:10.1038/2917
[7]	Alderton, G., Ward, W. and Febold, H. (1945) Isolation of lysozyme from egg white. The Journal of Biological Chemistry, 157, 43-58.
[8]	Kalfa, V.C. and Brogden, K.A. (1999) Anionic antimicrobial peptide-lysozyme interactions in innate pulmonary immunity. International Journal of Antimicrobial Agents, 13, 47-51. doi:10.1016/S0924-8579(99)00095-3
[9]	Smékal, F. (1973) Lysis of lyophilized Eschericial coli cell with egg-white lysozyme without ethylenediaminetetr acetic acid. Folia Microbiologica, 18, 146-148.
[10]	Thompson, H.L. and Wilton, J.M. (1991) Effects of an aerobiosis and aerobiosis on interactions of human poly morphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis. Infection and Immunity, 59, 932-940.
[11]	Sugahara, T., Murakami, F., Yoko Yamada, Y. and Sasaki, T. (2000) The mode of actions of lysozyme as an immunoglobulin production stimulating factor. Biochemica et Biophisica Acta, 1475, 27-34.
[12]	WHO/SDE/WSH/03.04/85 (2004) Monochloroacetic acid in drinking-water, background document for development of who guidelines for drinking-water quality. http://www.who.int/water_sanitation_health/dwq/chemicals/monochloroaceticacid.pdf
[13]	WHO/SDE/WSH/03.04/120 (2004) Trichloroacetic acid in drinking-water, background document for development of WHO guidelines for drinking-water quality. http://www.who.int/water_sanitation_health/dwq/chemicals/trichloroaceticacid.pdf
[14]	Herren-Freund, S.L., Pereira, M.A., Khoury, M.D. and Olson G. (1987) The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicology and Applied Pharmacology 9, 183-189. doi:10.1016/0041-008X(87)90325-5
[15]	Bull, R.J., Orner, G.A., Cheng, R.S., Stillwell, L., Stauber, A.J., Sasser, L.B., Lingohr, M.K. and Thrall, B.D. (2002) Contribution of Dichloroacetate and Trichloroacetate to Liver tumor induction in mice by trichloroethylene, Toxicology and Applied Pharmacology, 182, 55-65. doi:10.1006/taap.2002.9427
[16]	Daniel, F.B., DeAngelo, A.B., Stober, J.A., Olson, G.R. and Page, N.P. (1992) Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundamental and Applied Toxicology, 19, 159-68. doi:10.1016/0272-0590(92)90147-A
[17]	Cai, P., Boor, P.J., Khan, M.F., Kaphalia, B.S., Ansari, G.A. and Konig, R. (2007) Immuno- and hepato-toxicity of dichloroacetic acid in MRL(+/+) and B(6)C(3)F(1) mice, Journal of Immunotoxicology, 4, 107-115. doi:10.1080/15476910701337225
[18]	Berg, G.L. (1986) Farm chemicals handbook. Meister Publishing Company, Willoughby.
[19]	WSSA Herbicide Handbook Committee (1989) Herbicide handbook of the weed science society of America, 6th Edition, WSSA, Champaign.
[20]	Occupational Health Services, Inc. (1986) Material safety data sheet. OHS, Inc., Secaucus.
[21]	Jollès, P. (1967) Relationship between chemical structure and biological activity of hen egg-white lysozyme and lysozymes of different species. Proceedings of the Royal Society, 167B, 350-364.
[22]	Sakazaki, R., Yoshizaki, E., Tamura, K. and Kuramoch, S. (1984) Increased frequency of isolation of Pasteurella and Actinobacillus species and related organisms. European Journal of Clinical Microbiology & Infectious Diseases, 3, 244-248. doi:10.1007/BF02014894
[23]	Lefcoe, N.M. and Wonnacott, T.H. (1974) Chronic respiretory disease in four occupational groups. Archives of Environmental Health, 29, 143-146.
[24]	Yllner, S. (1971) Metabolism of chloroacetate-1-14C in the mouse. Acta Pharmacologica et Toxicological, 30, 69-80. doi:10.1111/j.1600-0773.1971.tb00635.x
[25]	Yllner, S. (1971) Metabolism of 1,1,2-trichloroethane- 1,2-14C in the mouse. Acta Pharmacologica et Toxicological, 30, 248-256. doi:10.1111/j.1600-0773.1971.tb00656.x
[26]	Bartsch, J., Malaveille, C., Barbin, A., Bresil, H., Tomatis, L. and Montesano, R. (1976) Mutagenicity and metabolism of vinyl chloride and related compounds. Environmental Health Perspectives, 17, 193-198. doi:10.1289/ehp.7617193
[27]	Hathway, D.E. (1977) Comparative mammalian metabolism of vinyl chloride and vinilidene chloride in relation to oncogenic potential. Environmental Health Perspectives, 21, 55-59. doi:10.1289/ehp.772155
[28]	Hayes, F.D., Short, R.D. and Gibson, J.E. (1973) Differential toxicity of monochloroacetate, monofluoroacetate and monoiodoacetate in rats. Toxicology and Applied Pharmacology, 26, 93-102. doi:10.1016/0041-008X(73)90089-6
[29]	Kulling, P., Anderson, H., Bostrom, K., Johansson, L., Lindstrom, B. and Nystrom, B. (1992) Fatal systemic poisoning after skin exposure to monochloroacetic acid. Clinical Toxicology, 30, 643-652. doi:10.3109/15563659209017948
[30]	Saghir, S.A., Fried, K. and Rozman, K.K. (2001) Kinetics of monochloroacetic acid in adults male rats after intravenouse injection of a subtoxic and a toxic dose. The Journal of Pharmacology and Experimental Therapeutics, 296, 612-622.
[31]	Doyle, R. (1984) Dalapon information sheet. Food and Drug Administration, Bureau of Foods, HFF-420.
[32]	Occupational Health Services, Inc. (1986) Material safety data sheet. OHS, Inc., Secaucus.
[33]	TOXNET (1975-1986) National library of medicine’s toxicology data network. Hazardous Substances Data Bank (HSDB). Public Health Service. National Institute of Health, US Department of Health and Human Services. NLM, Bethesda.
[34]	Hallenbeck, W.H. and Cunningham-Burns K.M. (1985) Pesticides and human health. Springer-Verlag, Berlin.